BGM Group Ltd (BGM)

Market Cap	48.58M
Revenue (ttm)	29.87M
Net Income (ttm)	-7.86M
Shares Out	7.15M
EPS (ttm)	-1.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,951
Open	6.77
Previous Close	7.03
Day's Range	6.75 - 7.02
52-Week Range	1.78 - 8.96
Beta	1.46
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2024

About BGM

BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jan 12, 2021
• Employees: 298
• Stock Exchange: NASDAQ
• Ticker Symbol: BGM
• Website: https://www.bgm.ltd

Financial Performance

Financial numbers in USD